A Study of PF-04217903 in Patients With Advanced Cancer
NCT00706355
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
16
Enrollment
INDUSTRY
Sponsor class
Stopped
See termination reason in detailed description.
Conditions
Neoplasms
Interventions
DRUG:
PF-04217903
Sponsor
Pfizer